Official UK procurement notice
Medtech Commercial Strategy 2026
Authority: Department of Health & Social Care (Central government)
What is being bought
Published requirement descriptionNHS England, the Department of Health and Social Care (DHSC), and NHS Supply Chain are jointly developing a MedTech Commercial Strategy. The aim is to bring cohesion, reduce duplication, improve efficiency, and create a unified approach that supports innovation and better patient outcomes across the full commercial lifecycle.
CPV: Medical equipments · Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedPipeline intelligence · planning stage: how this market runs before the tender is published
How Department of Health & Social Care buys Medical equipments (CPV 3310), and who usually turns up
Department of Health & Social Care’s published record next to the market for the same work. Frameworks and DPS are left out: they draw different bid counts. Whole-market view: Medical equipments (CPV 3310) →
How the contest usually goes
Winner shares use published awards; bid and price charts use contested lots.
i
How often small and medium firms win.
Share of awards where the winner’s size is known.
The counts under this question show how many awards have a known supplier size.
No small-firm winners recorded among this authority’s published awards in this sample.
i
How often local firms win similar work.
Winners with a registered address in the delivery region, out of awards with a known address.
Local means the winner is registered in the region where that award was delivered. The market figure counts awards delivered in Greater London (authority’s region).
A local branch does not count if the registered address is elsewhere.
Most of this buyer’s recorded winners were registered in the region where that award was delivered.
i
How long buyers here take to decide after bids close.
Middle value in days from the bid deadline to the award date, on competitions that published both.
Only decided tenders count, so slow ones still waiting are not in.
Half of these awards have an award date within 45 days of the bid deadline.
i
How often work is awarded with no recorded rival.
Direct awards and tenders where every published lot count shows one bid.
Both shares are minimums: some awards have no bid count.
Thin markets produce this too; it is not proof of a tailored specification.
Direct awards or one recorded bid are common here. Check the route before spending time on a bid.
How many bids did past lots attract?
i
How many bids past lots received.
Each colour is a bid-count range. Only competed lots with a published count are included.
Past bids do not predict this tender.
1 bid30% / 39%
2–328% / 50%
4–626% / 11%
7+16% / 0%
How did awards compare with estimates?
i
Where winning prices landed against estimates.
Each colour shows awards below, close to or above the published estimate, one lot at a time.
Past prices are a guide, not a bid price.
Below estimate50% / 83%
Within ±2%50% / 0%
Above estimate0% / 17%
Assess each lot i
What past awards tell you about each lot.
See the forecast, this buyer’s earlier suppliers and firms with relevant wins.
No supplier is confirmed as a bidder.
i
What past awards tell you about each lot.
See the forecast, this buyer’s earlier suppliers and firms with relevant wins.
No supplier is confirmed as a bidder.
Open a lot for its forecast, this buyer’s previous supplier and possible competitors, from published award history, not a bid list
Lot #1CPV 33No real estimate
This lot lists more than one class in CPV 33. The comparison uses that group.
i
How many bids this lot may attract.
The forecast uses similar past competitions. The bar shows either that forecast or past bid counts; the line below says which.
Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative. The bar shows 12 past lots.
A forecast, not a list of bidders.
1 bid25%
2–375%
4–60%
7+0%
i
Where the award price may land.
The forecast uses similar awards and the buyer’s estimate. The band covers the middle half of likely prices.
No comparable awards for this lot yet.
A statistical guide from past awards, not a price to bid.
Who has supplied this buyer on similar work? i
Who has done similar work for this buyer.
Past contracts are matched by buyer, title and type of work.
A past supplier may not bid again.
i
Who has done similar work for this buyer.
Past contracts are matched by buyer, title and type of work.
A past supplier may not bid again.
No earlier contract of this buyer matches this lot on the published record.
Who could compete for this lot? i
Who could compete for this lot?
Firms with relevant past wins. On a framework, we show firms on that agreement.
None is confirmed as a bidder.
i
Who could compete for this lot?
Firms with relevant past wins. On a framework, we show firms on that agreement.
None is confirmed as a bidder.
Candidate suppliers for this notice have not been worked out yet, so this is not a verdict that nobody fits.
About this data
- Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
- Two views, kept apart. The authority’s own track record and the wider market for the same kind of work sit side by side and are never mixed. Where the local picture is too thin, a figure widens to a broader market and says which one it used.
- Forecasts are labelled. The price forecast and its range, possible competitors and the earlier-work matches are our estimates from past awards: not published facts, not win chances and not price advice. Official notices do not say who is bidding.
- Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.
Procedure terms & legal framework
From the official record- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Planned procurement
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 5 Feb 2026, 17:53 GMT
- Last source update
- 6 Mar 2026, 15:55 GMT
- FTS notice number
2026/S 000-020568- Latest notice
- Preliminary market engagement notice (UK2)
- Classification (CPV)
- Delivery area
- Not published
- Official registry OCID
ocds-h6vhtk-06498aFind a Tender
How it was run
Official notice- Submission deadline
- —
Timeline
5 Feb 2026 → 6 Mar 2026 · 4 dates- Contract starts264 days ago5 Feb 2026
- Planning notice published264 days ago5 Feb 2026, 17:53 GMT
- Latest notice published235 days ago6 Mar 2026, 15:55 GMT
- Market engagement234 days ago6 Mar 2026, 23:59 GMT
Please note the response window for this engagement has been extended until 17:00 on 13th March 2026.
MedTech plays a vital role in enabling the NHS to deliver high quality, innovative and patient centred care. From diagnostics and treatment pathways to digital transformation and earlier intervention, MedTech is central to achieving the ambitions set out in the 10 Year Health Plan. However, the current commercial landscape is fragmented, creating challenges for buyers in navigating the market, delivering value, and supporting consistent adoption at scale.
With annual MedTech spend at approximately £13 billion, there is a significant opportunity for the NHS to both improve outcomes and productivity, but also to align with wider government priorities for innovation, growth and the UK life sciences sector.
To address these challenges, NHS England, the Department of Health and Social Care (DHSC), and NHS Supply Chain are jointly developing a MedTech Commercial Strategy. The aim is to bring cohesion, reduce duplication, improve efficiency, and create a unified approach that supports innovation and better patient outcomes across the full commercial lifecycle.
The Medtech Commercial Strategy seeks to:
- Simplify and strengthen commercial pathways
- Improve value for money and patient outcomes
- Provide clearer expectations for suppliers
- Reduce duplication and unwarranted variation
- Align with wider government priorities for innovation and growth
- Support more consistent and informed decision making across the NHS
This market engagement is being issued on Thursday 5th February 2026. The closing date for responses is on: 12:00pm, Friday 13th March 2026.
Please respond to the questions listed in the survey using this link: forms.office.com/e/J46XXPTNv8 ↗
A PDF version of the survey is available here: atamis-1928.my.salesforce.com/sfc/p/0O000000rwim/a… ↗
Please submit responses via the Forms survey link only.
This engagement is designed to gather feedback from organisations in the Medtech sector to directly shape the Medtech Commercial Strategy.
The survey seeks honest and practical reflections on what currently works well, the challenges faced, and where change is most needed.
To support the survey, we are running information and engagement webinars. The webinars will share the purpose, scope, ambition and early discovery insights of the strategy, with an interactive engagement exercise to inform the discovery phase.
The webinars are taking place on the dates below. Please register for one of the webinars using the links below:
Thursday 12th February 3pm-4pm: events.teams.microsoft.com/event/f889be9a-b16c-… ↗
Thursday 10th March 3pm-4pm - events.teams.microsoft.com/event/ce796664-4e20-… ↗
During the webinars, we will:
- Provide an overview of the objectives and scope of the MedTech Commercial Strategy
- Share how this work will help shape future NHS commercial direction
- Set out key routes for engagement
- Run an interactive session to gather views on opportunities, challenges, and potential improvements
This notice does not constitute a call for competition. The aim of this engagement is to inform the development of the Medtech Commercial Strategy.
For further guidance on how to complete the questionnaire and information about the market engagement please use this link: atamis-1928.my.salesforce.com/sfc/p/0O000000rwim/a… ↗
Notice history
2 events · 2 releases on Find a Tender · since 5 Feb 2026- Preliminary market engagement notice published5 Feb 2026, 17:53 GMTUK2
- Preliminary market engagement notice published6 Mar 2026, 15:55 GMTUK2
Published amendments (1)
Extension of response window
Commercial outcome & contract awards
Pipeline notice- Awards (0)
- No award published
- Contracts (0)
- No contract published
- Bid statistics
- No aggregate bid statistics published
Contracting authority & participating public bodies
Official documents & specifications (2)
Official links; attachments are not copiedNotices published for this procedure
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender